Pharmacokinetics and Safety of Twice-daily Ritonavir-boosted Atazanavir With Rifampicin

Gausi, K; Mugerwa, H; Siccardi, M; Montanha, MC; Lamorde, M; Wiesner, L; D'Avolio, A; Mcilleron, H; Wilkins, E; De Nicolo, A; Maartens, G; Khoo, S; Kityo, C; Denti, P; Waitt, C

Gausi, K (通讯作者),Groote Schuur Hosp, Dept Med, K45 Old Main Bldg, ZA-7925 Cape Town, Western Cape, South Africa.

CLINICAL INFECTIOUS DISEASES, 2023; ():

Abstract

Background Critical drug-drug interactions (DDI) and hepatotoxicity complicate concurrent use of rifampicin and protease inhibitors. We investigated w......

Full Text Link